MY ROBOTS / Recognition

Selected Programs & Global Recognition

Selected healthcare, AI, and global business-development programs. Selection rates are quantified only when application totals are public.

6 programs2024–2026Updated July 11, 2026

2026

Selected

JETRO GSAP 2026 — StartX AI Course

Cohort1 of 20 companies in the AI course

Selection rateApplication volume and selection rate for the JETRO course are not public

An AI acceleration program delivered with Stanford-originated StartX, supporting U.S. market entry, business development, mentorship, and Silicon Valley network building. JETRO notes that StartX's existing U.S. program receives more than 300 applications with an acceptance rate below 10%.

Official JETRO page ↗The 20-company cohort is published by JETRO; MY ROBOTS' selection status is based on its selection notice.

2026

Selected

J-StarX US Healthcare Breakthrough — Foundational Course

Cohort1 of 5 selected companies

Selection rateApplication volume and selection rate are not public

A U.S. healthcare market-entry program delivered with Mayo Clinic Platform_Accelerate, Mayo Clinic Berg Innovation Exchange, and Kicker Ventures, providing business-development education, individual mentorship, and ecosystem connections.

Official JETRO page ↗JETRO published a maximum cohort size of 10; the five-company selected cohort is based on the selection notice.

2026

Shortlisted

Qualcomm AI Program for Innovators 2026 — APAC

Cohort1 of up to 15 startups across APAC

Selection rateApplication volume and selection rate are not public

An APAC program for startups in Japan, Singapore, and South Korea, supporting edge-AI development and commercialization through Qualcomm Dragonwing and Snapdragon platforms, Arduino Uno Q, Qualcomm AI Hub, six months of one-to-one mentorship, development support, and Demo Day.

Official Qualcomm page ↗The up-to-15-startup cohort is published by Qualcomm.

2025

Selected

Mayo Clinic Berg Innovation Exchange 2025

Cohort1 of 10 companies worldwide

Selection rateApplication volume and selection rate are not public

An international program leveraging Mayo Clinic's clinical expertise and innovation network to evaluate clinical value, market potential, business development, and pathways for U.S. expansion.

Mayo Clinic Platform ↗The cohort size is based on the program notice.

2025

Advanced to Phase 2

J-StarX Medtech Course — Medtech Actuator

CohortPhase 1: 1 of 15 / Phase 2: 1 of 7

Selection rateApplication volume and selection rate are not public

A medtech acceleration program delivered with Medtech Actuator, supporting market validation, global expansion strategy, regulatory and reimbursement planning, pricing, clinical-trial readiness, and engagement with investors and commercial partners.

JETRO selected-company announcement ↗JETRO published 15 Phase 1 companies and a 5–7-company Phase 2 cohort; advancement into a seven-company Phase 2 cohort is based on the program notice.

2024

Selected

J-StarX Silicon Valley Extended Program 2024

Cohort1 of 30 companies in the domestic bootcamp cohort

Selection rateApplication volume and selection rate are not public

A hands-on U.S. market-entry program combining a domestic bootcamp, individual mentorship, Silicon Valley market validation, investor and customer development, and ecosystem networking.

Official JETRO page ↗The 30-company 2024 cohort is based on the program notice; the linked page is the current official program overview.